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Left unrepaired, DNA interstrand crosslinks represent impassable hurdles for DNA replication, 
and their removal is a complicated stepwise process involving a variety of enzymes. In a recent 
paper in Science, Knipscheer et al. (2009) demonstrate that the Fanconi Anemia protein FANCD2 
promotes multiple steps of the crosslink repair process.Like good housekeepers, cells spend 
considerable energy caring for their 
genetic material, mopping up DNA 
damage that may alter the reading of 
their genetic information. The most dif-
ficult type of damage to repair, and at 
the same time the most detrimental, 
are DNA interstrand crosslinks (ICLs). 
ICLs block DNA replication, making 
their removal an essential requirement 
for cell survival. Defects in ICL repair 
underlie Fanconi Anemia (FA), and the 
severe clinical symptoms of the disorder 
(blood marrow failure, developmental 
abnormalities, and cancer predisposi-
tion, often leading to an early death) tes-
tify to the toxicity of ICLs (Moldovan and 
D’Andrea, 2009; Patel and Joenje, 2007). 
Yet, how the proteins in the FA pathway 
protect against ICLs has long remained a 
mystery. Using a cell-free system, Knip-
scheer et al. (2009) now show that FA 
proteins are directly involved at several 
steps in the process of ICL repair.
Removal of ICLs mostly occurs in 
S phase and involves the stepwise 
involvement of nucleases, specialized 
DNA polymerases that bypass lesions, 
and factors that mediate homologous 1222 Cell 139, December 24, 2009 ©2009 Erecombination (Moldovan and D’Andrea, 
2009). In prior work the authors devised 
an experimental approach to investigate 
replication-dependent repair of ICLs 
using a cell-free replication system of egg 
extracts from the frog Xenopus (Raschle 
et al., 2008). Their system reveals that 
replication forks, converging from both 
directions, initially stop 20–40 nucle-
otides from the crosslink (Figure 1). One 
of the forks subsequently moves further 
and stops again just before the crosslink 
(at position −1). Nucleolytic incisions on 
both sides of the crosslink, and DNA 
polymerization across the lesion, restore 
one of the chromatids, whereas the other 
chromatid is most likely repaired through 
homologous recombination. In an ele-
gant application of their crosslink repair 
system, Knipscheer et al. now show 
that loss of proteins in the FA pathway 
can block both the incision and bypass 
steps.
Thirteen proteins cooperate in the FA 
pathway. Eight of these proteins form a 
ubiquitin ligase complex that monou-
biquitinates the substrates FANCD2 and 
FANCI. In the new study, immunodeple-
tion of FANCD2 from the egg extracts lsevier Inc.(which also codepletes its heterodimeric 
partner FANCI) dramatically inhibits 
crosslink repair, demonstrating that FA is 
a true DNA repair syndrome. Nucleotide 
insertion opposite the ICL is blocked in 
the absence of FANCD2, such that the 
leading strand progresses only to posi-
tion −1. Also, the two incisions required 
to unhook the crosslink are not detected 
in extracts depleted of FANCD2. All 
defects can be rescued by adding back 
the recombinant FANCD2-FANCI com-
plex, but not by adding back a complex 
containing a point mutant of FANCD2 
that cannot be ubiquitinated. Accord-
ingly, when the investigators examine the 
timing of FANCD2 ubiquitination, they 
find that this modification occurs pre-
cisely when the replication fork reaches 
the −1 position. FANCD2 ubiquitination, 
known to be essential for crosslink tol-
erance, is therefore required to advance 
the replication fork across the crosslink, 
by orchestrating the unhooking of the 
crosslink and DNA synthesis across the 
lesion.
Bypass of DNA lesions is a poten-
tially mutagenic process performed by 
specialized polymerases. The FA path-
way is known to be required for muta-
genesis, and the polymerase Rev1 is 
epistatic to FA and may function in FA-
dependent lesion bypass (Mirchandani 
et al., 2008; Niedzwiedz et al., 2004). 
The finding that FANCD2 ubiquitination 
promotes crosslink bypass supports a 
model in which Rev1 is recruited, via its 
ubiquitin-binding domain, to the ubiq-
uitinated FANCD2 protein. This model is 
analogous to the recruitment of Y-family 
polymerases, such as DNA polymerase 
η, by monoubiquitinated PCNA, which 
is required for the polymerase to bypass 
lesions induced by UV light (Bienko et 
al., 2005). It should now be possible to 
test this model for crosslink bypass by 
depleting Rev1 from egg extracts in 
this cell-free replication system, and by 
assessing whether Rev1 and ubiquit-
inated FANCD2 interact. As human cells 
have at least 15 polymerases, a different 
mutagenic polymerase might also be 
involved. Interestingly, only about 25% 
of crosslinked plasmids are recovered 
as repaired, error-free DNA molecules 
(Knipscheer et al., 2009), raising the 
possibility that some sites are repaired 
with errors. Investigating the mutation 
spectrum of the repaired templates may 
help identify the relevant polymerases. 
Alternatively, FANCD2 may not directly 
recruit a polymerase but rather stabilize 
some structure at the crosslink site, thus 
indirectly allowing a nucleotide insertion 
event.
How the FANCD2 protein regulates 
the DNA incisions flanking the crosslink 
is even more intriguing. FANCD2 has no 
known enzymatic activity, possesses no 
obvious nuclease domains, and has no 
known associated nucleases. Perhaps 
a cryptic nuclease activity of FANCD2 is 
activated by monoubiquitination when a 
Figure 1. FANCD2 Monoubiquitination in 
the Repair of Interstrand Crosslinks 
Crosslink repair is initiated by stalling of the two 
replication forks on either side of the interstrand 
crosslink (ICL). One of the forks subsequently 
moves to the crosslink site. By the time the fork 
reaches position −1, FANCD2 has been monou-
biquitinated by the Fanconi Anemia (FA) core 
complex. Ubiquitinated FANCI-FANCD2 then 
promotes nucleolytic incisions and the unhook-
ing of the crosslink, allowing bypass of the lesion 
by polymerases. Finally, homologous recombina-
tion concludes the repair reaction. Monoubiquit-
inated FANCD2 may directly activate nucleolytic 
processes (top inset), recruit translesion synthesis 
polymerases (bottom inset), or both.Cell 139, Dereplication fork encounters a crosslink. 
Alternatively, ubiquitinated FANCD2 may 
transiently recruit some known nucle-
ase complex, such as Mus81-Eme1, 
Xpf-Ercc1, or the newly described Slx4 
complex.
At present, the Xenopus experimental 
system cannot temporally dissociate the 
incision and bypass steps. Although it is 
logical to assume that incision occurs 
first, allowing bypass by a polymerase 
such as Rev1, the alternative possibil-
ity should not be excluded: nucleotide 
insertion opposite the ICL may create 
a DNA structure that promotes inci-
sion. Also, it is possible that the proxi-
mal incision occurs first, followed by the 
lesion bypass step and the distal inci-
sion. In either case, FANCD2 may only 
be required for the first activity in the 
stepwise process. Depletion of FANCD2 
may thus only indirectly affect the sub-
sequent steps. Alternatively, FANCD2 
may directly activate both incision and 
bypass, irrespective of their order of 
occurrence.
Recent studies indicate that the regu-
lated deubiquitination of FANCD2 by the 
ubiquitin protease complex, USP1/UAF1, 
is also required for crosslink repair (Mol-
dovan and D’Andrea, 2009). Whether 
deubiquitination is required for incision 
or lesion bypass is also unknown. The 
Xenopus system may be useful in resolv-
ing these questions as well.
An apparent shortcoming of this 
model system is its inability (to date) to 
decipher the roles of the FA pathway in 
the last part of the ICL repair process, 
the step involving homologous recom-
bination. Only the repair of the chroma-
tid with the unhooked crosslink can be 
investigated, probably due to degrada-
tion of the other sister chromatid that 
is broken by incisions. Therefore, the 
repair process in this system terminates 
before the final recombination step. It 
is possible that FANCD2 plays only an 
indirect role in this final step, simply 
handing off the product of the incision 
and insertion steps to the machinery 
for homologous recombination. This 
machinery most likely involves the 
recombination mediator BRCA2, identi-
fied as the FA factor FANCD1 (Howlett 
et al., 2002), and its binding partner, 
FANCN. Alternatively, the FA pathway 
may be actively involved in homologous cember 24, 2009 ©2009 Elsevier Inc. 1223
recombination. This possibility is sup-
ported by evidence that FANCD2 and 
FANCI are required for the homologous 
recombination induced by DNA double-
strand breaks (Moldovan and D’Andrea, 
2009), suggesting a general role of the 
FA pathway in promoting recombina-
tion. It is currently unclear whether this 
function represents a direct participa-
tion of the FA pathway (for example, 
recruitment of factors that mediate 
homologous recombination), or a more 
indirect one, such as inhibition of alter-
native competing repair pathways (such 
as the error-prone nonhomologous end-
joining pathway).
Despite these shortcomings, Xenopus 
egg extracts should allow the identifica-
tion and characterization of the nucle-
ases and polymerases involved in ICL 
repair and help to elucidate how these 
activities are controlled by the FA path-1224 Cell 139, December 24, 2009 ©2009 E
Sensations such as touch, temperature, 
itch, and pain are mediated by primary 
somatosensory neurons that detect 
thermal, mechanical, and chemical 
cues and relay this information to the 
central nervous system (Figure 1). Itch, 
or pruritus, is defined as the unpleas-
ant sensation that elicits scratching 
behavior. In this sense, itch is quite dis-
tinct from pain, the application of which 
causes the hasty withdrawal of the 
affected body part. Nevertheless, pain 
and itch stimuli can sometimes interact; 
for instance, a pain sensation can inhibit 
an itch sensation. It even has been sug-
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The itch sensation results from t
underlying molecular mechanism
some members of the Mrgpr cla
antimalarial drug chloroquine.way. This knowledge may, over time, 
lead to better therapeutic strategies for 
FA patients.
Together with the recently described 
role of the FA pathway in activating the 
DNA-damage checkpoint induced by 
crosslinks (Ben-Yehoyada et al., 2009), 
these new findings paint the picture 
of a dynamic, multifaceted pathway 
involved in numerous steps in the cellular 
response to DNA crosslinks.
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mary sensory neurons express members 
of a group of closely related receptors 
belonging to the Mrgpr family. There are 
?24 potentially functional Mrgpr genes in 
mice but, strikingly, only eight in humans 
(Dong et al., 2001). Mrgpr expression is 
highly restricted to primary sensory neu-
rons, hinting at a somatosensory role. 
However, their function has remained 
enigmatic. The new study by Liu et al. 
(2009) indicates that some of these recep-
tors are involved in an itch sensation that 
is independent of that mediated by the 
best known itch inducer, histamine.
erve endings in the skin, but the 
 Liu et al. (2009) now report that 
 mediate the itch caused by the 
